Calcium Containing Sulfur Compound (e.g., Calcium Sulfate, Etc.) Patents (Class 424/696)
  • Publication number: 20100112075
    Abstract: Microparticles or granules intended for use in the zootechnical field, constituted by a core which contains a substance having a pharmacological action, a food supplement or a diagnostic medium, intimately mixed or adsorbed with a hydrated silicate of magnesium, aluminum, calcium and sodium (smectite, montmorillonite or bentonite); the core is coated with a double fatty layer constituted by two fats or waxes, of which the one having the highest melting point constitutes the inner layer while the one having the lowest melting point is arranged so as to form the outer layer.
    Type: Application
    Filed: July 31, 2007
    Publication date: May 6, 2010
    Applicant: EURHEMA S.R.I.
    Inventors: Ruggero Bettini, Lauro Arduini, Francesca Bertolini, Claudia Camellini
  • Publication number: 20100112088
    Abstract: The subject invention pertains to materials and methods for the prevention and treatment of disease conditions associated with oxidative stress or a compromised reducing environment, including inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. Therapeutic compositions of the invention include compositions that can neutralize hydrogen peroxide, such as reducing agents and oxidizing agents. In one embodiment, a therapeutic composition of the invention comprises a reducing agent such as sodium thiosulfate. Therapeutic compositions of the invention can optionally include compounds with antibacterial activity, compositions that inhibit bacterial adherence to cells and tissue, compositions that inhibits epithelial lipid peroxidation, compositions that add viscosity to a solution, compositions that inhibit most cells, and/or compositions that help to seal or repair tight junctions between cells of the colonic epithelium of the gastrointestinal tract.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 6, 2010
    Inventor: Jay Pravda
  • Publication number: 20100092559
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: October 1, 2009
    Publication date: April 15, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100055183
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: August 25, 2009
    Publication date: March 4, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100040628
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: August 11, 2009
    Publication date: February 18, 2010
    Applicant: OsteoGeneX, Inc
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100040655
    Abstract: The present invention provides the use of nanoparticles of a compound of general formula MnXy, where M is (i) a metal selected from the group consisting of Calcium (Ca), Aluminium (Al), Zinc (Zn), Nickel (Ni), Tungsten (W) or Copper (Cu); or (ii) a non-metal selected from the group consisting of Silicon (Si), Boron (B) or Carbon (C); in which n is equal to 1, 2, or 3, and X is (iii) a non-metal selected from the group consisting of Oxygen (O), Nitrogen (N), or Carbon (C); or (iv) an anion selected from the group consisting of phosphate (PO43?), hydrogen phosphate (HPO42?), dihydrogen phosphate (H2PO4?), carbonate (CO3), silicate (SiO42?), sulphate (SO42?), nitrate (NO3?), nitrite (NO2?); in which y is equal to 0, 1, 2, 3 or 4; for use in reducing and/or preventing virus transmission. Articles of protective clothing or filters are provided in which the fibres are coated with said nanoparticles for use in reducing and/or preventing virus transmission.
    Type: Application
    Filed: February 16, 2007
    Publication date: February 18, 2010
    Applicants: QUEEN MARY & WESTFIELD COLLEGE, INTRINSIQ MATERIALS LIMITED, RETROSCREEN VIROLOGY LIMITED
    Inventors: Guogang Ren, John Sidney Oxford, Paul William Reip, Robert Lambkin-Williams, Alexander Mann
  • Patent number: 7658768
    Abstract: Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended.
    Type: Grant
    Filed: October 15, 2007
    Date of Patent: February 9, 2010
    Assignee: Wright Medical Technology, Inc.
    Inventors: Leasa C. Miller, Kelly Coupe Richelsoph, Jon P. Moseley
  • Patent number: 7628851
    Abstract: The present invention relates in general to implantable compositions, and method for preparing same, containing a calcium salt-containing component, optionally demineralized bone, a plurality of discrete fibers, optionally a flow additive, and optionally continuous reinforcing fibers or an array of organized fibers in the form of mesh. Advantageously, the discrete fibers have a specific aspect ratio (length/diameter) from about 50:1 to about 1000:1. The addition of a small amount of discrete fibers and/or the continuous reinforcing fibers or fiber mesh can cause drastic increases in certain mechanical properties including flexural strength, flexural toughness, and/or screw pullout strength.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: December 8, 2009
    Assignee: Synthes USA, LLC
    Inventors: Bryan Monro Armitage, Ira C Ison, Mark Thomas Fulmer, Sean Hamilton Kerr, Michael Lehmicke, Patrick Leamy, William Schiffer
  • Publication number: 20090148489
    Abstract: A bioabsorbable material suitable for implanting within a human body, the material including fibers of a composite of a synthetic bioabsorbable polymer such as poly-lactic acid, and a particulate bioactive filler such as calcium phosphate powder. The fibers are discontinuous with non-uniform cross-sections and non-uniform cross-sectional areas. The surface topography provided by the fibers provides a substrate which is more amenable to cellular colonization than prior materials.
    Type: Application
    Filed: November 11, 2005
    Publication date: June 11, 2009
    Inventor: John Joseph Cooper
  • Patent number: 7431918
    Abstract: An antiperspirant composing calcium sulfate hemihydrate in an anhydrous state or in an anhydrous composition and method of treating hyperhidrosis.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: October 7, 2008
    Inventors: Walter B. Shelley, Harry J. Hurley
  • Publication number: 20080233165
    Abstract: A bone-growth stimulating composition for forming a resorbable implant, methods for making such a composition and a corresponding putty/paste material. In some embodiments of the invention, such a material includes a plurality of particles having a predetermined size and comprising a first calcium sulfate compound, a resorbable polymer in a predetermined weight ratio and a growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 25, 2008
    Applicant: Biolok International, Inc.
    Inventors: Harold Alexander, John L. Ricci, Sachin Mamidwar
  • Publication number: 20080226749
    Abstract: The present invention discloses a pharmaceutical composition for inhibiting a snore symptom, which comprises medicinal material of Uncaria rhynchophylla. The above pharmaceutical composition of the present invention also comprises medicinal materials of Uncaria rhynchophylla, Ephedra, Prunus armeniaca, and Glycyrrhiza uralensis.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 18, 2008
    Applicant: Brion Research Institute of Taiwan
    Inventors: Shuenn-Jyi Sheu, Hsiao-Yin Yeh, Wu-Che Wen, Ching-Che Lin, Chen-Ying Chiang
  • Publication number: 20080213359
    Abstract: The present invention provides a method for facilitating repair of an area of bone by providing hemihydrate calcium sulfate particles, mixing the particles with an aqueous solution to obtain a paste, applying the paste to an area of bone in need of repair, and allowing the paste to set.
    Type: Application
    Filed: January 30, 2008
    Publication date: September 4, 2008
    Inventors: YoungBum Park, Rosemary Dziak, Robert J. Genco, Mark Swihart, Hiran Perinpanayagam
  • Publication number: 20080199541
    Abstract: The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
    Type: Application
    Filed: January 31, 2008
    Publication date: August 21, 2008
    Applicant: IKARIA HOLDINGS
    Inventors: Kevin J. Tomaselli, Paul A. Hill, Thomas L. Deckwerth, Edward Wintner, Csaba Szabo
  • Publication number: 20080166430
    Abstract: The present invention relates to a new composition and methods for preventing the transmission of enterohemorrhagic E. coli and other foodborne pathogens to farm animals. In accordance with one embodiment, a composition comprising lactic acid and acidic calcium sulfate, and a compound selected from the group consisting of caprylic acid, sodium benzoate, butyric acid and chlorine dioxide is provided as an inhibitor of the growth of enterohemorrhagic E. coli and other foodborne pathogens.
    Type: Application
    Filed: January 25, 2006
    Publication date: July 10, 2008
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Michael P. Doyle, Tong Zhao
  • Publication number: 20080160060
    Abstract: The present invention provides a method of promoting local bone growth by administering a therapeutic amount of a Sost antagonist to a mammalian patient in need thereof. Preferably, the Sost antagonist is an antibody or FAB fragment selectively recognizing any one of SEQ ID NOS: 1-23. The Sost antagonist may be coadministered together or sequentially with a matrix conducive to anchoring new bone growth. Orthopedic and Periodontal devices comprising an implantable portion adapted to be permanently implanted within a mammalian body and bearing an external coating of a Sost antagonist are also disclosed, as it a method of increasing bone density by administering to a mammalian patient a therapeutic amount of a Sost antagonist together with an antiresorptive drug.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 3, 2008
    Applicant: OSTEOGENEX INC.
    Inventor: Debra L. Ellies
  • Publication number: 20080145449
    Abstract: A patient with a disease associated with a receptor having a cysteine residue is treated with a thiol reactive agent. The diseases include neurodegenerative diseases. Diseases characterized by skeletal muscle atrophy are also treated.
    Type: Application
    Filed: February 22, 2008
    Publication date: June 19, 2008
    Inventor: Jonathan S. Stamler
  • Patent number: 7387799
    Abstract: The present invention relates to an anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use. The composition of the present invention mainly includes the following three ingredients in an adequate ratio: (A) a metal compound having catalytic function; (B) ionic compound, and (C) an additive. The anti-bacterial, anti-virus, and anti-fungus composition of the present invention is capable of destroying viruses as well as killing bacterial and fungi. Therefore, the composition can be formulated as an aerosol and a film for applying to protection devices such as respirators, masks, gloves, filters, condoms, etc. The present composition can also be used in household, vehicle, hospital, school, restaurant, hotel, internet coffee shop for applying to filter of air-conditioner, tap, stool, interior of elevator and its keyboard.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: June 17, 2008
    Assignee: Well-Being Biochemical Corp.
    Inventors: Jih-Ru Hwu, Shwu-Chen Tsay
  • Patent number: 7374776
    Abstract: The present invention relates to a composition for bone-filling, more particularly, to a bone-filling composition for stimulating bone-formation and bone consolidation comprising calcium sulfate and viscous biopolymers. The composition of the present invention can easily be administered into the missing part of injured bone. Since the composition of the present invention does not diffuse to surrounding organs, it can effectively be used for bone-filling material suitable for body.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: May 20, 2008
    Assignee: Regen Biotech, Inc.
    Inventors: In-San Kim, Byung Chae Cho
  • Patent number: 7371408
    Abstract: A bone graft substitute composition comprising calcium sulfate; a mixing solution selected from the group consisting of sterile water, sodium chloride, phosphate buffered saline, potassium chloride, and sodium sulfate; and a plasticizing substance selected from the group consisting of carboxymethylcellulose, polyvinyl alcohol, methycellulose, and hydroxypropyl methylcellulose.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventors: Donald W. Petersen, Warren O. Haggard, Donald A. Randolph, Cary P. Hagan
  • Patent number: 7371409
    Abstract: A bone graft substitute composition can include essentially of calcium sulfate, a mixing solution, and a plasticizing substance. A bone graft substitute composition can include calcium sulfate, demineralized bone matrix, cancellous bone, a plasticizing substance, and a mixing solution.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventors: Donald W. Petersen, Barbara E. Blum
  • Patent number: 7371410
    Abstract: A bone graft substitute composition can include essentially of calcium sulfate, a mixing solution, and a plasticizing substance. A bone graft substitute composition can include calcium sulfate, demineralized bone matrix, cancellous bone, a plasticizing substance, and a mixing solution.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventor: Donald W. Petersen
  • Patent number: 7294349
    Abstract: An emulsion comprising: water; hydrophilic particles; and hydrophobic particles; wherein the hydrophilic and hydrophobic particles form shells encapsulating a gas that are suspended in the water, said shells comprising an external layer of hydrophilic particles and an internal layer of hydrophobic particles adjacent to the layer of hydrophilic particles.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: November 13, 2007
    Assignee: Or Le Or Ltd.
    Inventor: Dov Ingman
  • Patent number: 7291179
    Abstract: Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: November 6, 2007
    Assignee: Wright Medical Technology, Inc.
    Inventors: Leasa C. Miller, Kelly Coupe Richelsoph, Jon P. Moseley
  • Patent number: 7255882
    Abstract: Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter function and are non-addictive. Use of the enkephalinase inhibitor D-phenylalanine, the GABA precursor glutamine, the serotonin precursor 5-HTP, glycine, and taurine, in combination with coenzymatic functionality of folic acid is preferred for activation of ligand-gated Cl? channel in the central nervous system. Food supplement embodiments provide the human body nutritional supplements to intake certain neurotransmitter precursor substrates, thereby enabling patients of all ages to self-regulate their ability to quell perturbations to equilibrium and simultaneously to adverse effects upon normal physiological and psychological functioning attributable to induced anxiety and panic associated with benzodiazepine withdrawal.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: August 14, 2007
    Inventors: Albert Howard Bieser, Terry Leo Neher
  • Patent number: 7094416
    Abstract: It discloses a facial treatment mask that can be applied directly on the user's skin, with improved organoleptic properties, along with a process for preparing the product that serves as a base for the mask. Said product consists of the mixture of two separate phases, immediately prior to application. Each phase consists of a series of ingredients which give them their appearance of a suspension and gel respectively, so that when combined together, they form a genuine emulsion. The process for preparing each phase includes various steps of mixing and combining their respective ingredients, with the help of blending and kneading devices that operate for pre-determined periods of time. The application is conducted within a maximum period of approximately 4 to 5 minutes, and the polymerisation or setting is achieved within a minimum time frame of approximately 15 minutes.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: August 22, 2006
    Assignee: Emprediver, S. L.
    Inventor: Jose Sequi Gonzalez
  • Patent number: 7063865
    Abstract: A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc) when taken as recommended. The composition includes an effective amount of (I)-glycine, (I)-glutathione, thiamine, magnesium, selenium, molybdenum. Other vitamins, mineral compounds, flavoring, coloring, and solubility agents may also be added.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: June 20, 2006
    Inventors: Jeremy Park Jones, Peter Kevin Dobler
  • Patent number: 7029703
    Abstract: A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.
    Type: Grant
    Filed: September 9, 2002
    Date of Patent: April 18, 2006
    Assignee: Metagenics, Inc.
    Inventors: Kim C. Krumhar, Holly A. Johnson
  • Patent number: 6863898
    Abstract: Hairy hoof warts in animals are treated by topically administering an effective amount of a composition of aspirin or other compound or derivative of salicylic acid that preferably contains at least 50% by weight and more preferably between about 75% and 100% by weight aspirin or other compound or derivative of salicylic acid. A preferred composition includes aspirin, hydrated lime, sodium bentonite, and chalk or iron oxide.
    Type: Grant
    Filed: November 14, 2002
    Date of Patent: March 8, 2005
    Inventor: Michael D. Clawson
  • Patent number: 6841172
    Abstract: The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron complexed with one or more low molecular weight anions is administered to a patient by transfer from dialysate. A complex selected according to the invention is non-polymeric; soluble in an aqueous medium; chemically stable, thereby preventing the dissociation of iron ions from the anions under conditions according to the invention; and can be well absorbed into blood and the living body. Also provided are dialysate compositions including therein an iron complex selected according to the invention, and dialysate concentrates which may be diluted to yield an inventive dialysate composition.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: January 11, 2005
    Assignee: HemoCleanse, Inc.
    Inventor: Stephen R. Ash
  • Publication number: 20040208934
    Abstract: The production and use of inorganic-polymer complexes for the controlled release of compounds including medicinals are disclosed. Advantageously, the inorganic used is calcium sulfate.
    Type: Application
    Filed: May 5, 2004
    Publication date: October 21, 2004
    Applicant: Royer Biomedical, Inc.
    Inventor: Garfield P. Royer
  • Publication number: 20040105896
    Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.
    Type: Application
    Filed: July 10, 2003
    Publication date: June 3, 2004
    Applicant: Crosfield Limited
    Inventors: Norman B. Roberts, Maurice Webb, Benjamin J. Rankin
  • Publication number: 20040076688
    Abstract: The composition and process for preparing an anti-hemorrhoid composition which comprises providing a predetermined effective amount of natural substances of the genera Glycyrrhizae Radix, Testudinis Carapax, Cervi Parvum Cornu, Rhei Rhizoma, Ephedrae Herba, Natrii Sulfas, Moutan Radicis Cortx, Menthae Herba, Pinelliae Rhizoma, Pasoniae Radix, Acontii Tuber, Corni Fructus, Gypsum, Ginseng Radix, Cinnabaris, Talcum and Pelladendri Radix in an aqueous medium to form an initial mixture, extracting the initial mixture with water at a temperature of about 70°-80° C. for 1-2 hours to produce an aqueous mixture, filtering the aqueous mixture to produce a filtrate, and evaporating the filtrate to a moisture content of 30% to produce an extract which can be used as a treatment for hemorrhoid diseases.
    Type: Application
    Filed: October 21, 2002
    Publication date: April 22, 2004
    Inventor: Chan Sik Park
  • Patent number: 6720013
    Abstract: A mineral supplement or feed for ruminant animals, especially deer, contains effective amounts of sulfur and garlic to repel insects from the animals. By inducing the repellant into the animal via ingestion of the mineral supplement or feed, disease and stress in the animals as caused by the insects is reduced.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 13, 2004
    Assignee: B & L Technologies
    Inventors: Louis B. Johnson, William Whitehead
  • Patent number: 6709744
    Abstract: Bioactive substantially silica-free glass material with a hydroxyapatite layer thereon is described, as well as methods for producing hydroxyapatite on a borate glass.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: March 23, 2004
    Assignees: The Curators of the University of Missouri, Vita Licensing, Inc
    Inventors: Delbert E. Day, Erik M. Erbe, Marina Richard, Joshua A. Wojcik
  • Patent number: 6692775
    Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: February 17, 2004
    Assignee: Aqua Med, Inc.
    Inventor: John D. Young
  • Patent number: 6689392
    Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: February 10, 2004
    Assignee: Agricare Ltd.
    Inventor: Ran Lifshitz
  • Patent number: 6682762
    Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: January 27, 2004
    Assignee: Heart-O-Dixie Animal Nutrition, LLC
    Inventor: Martin Kenneth Register
  • Patent number: 6652887
    Abstract: A composition includes calcium sulfate hemihydrate, an accelerant material, e.g., calcium sulfate dihydrate, a plasticizing material, a mixing solution, and demineralized bone matrix having a moisture content of between about 10 and about 30 weight percent.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: November 25, 2003
    Assignee: Wright Medical Technology, Inc.
    Inventors: Kelly Coupe Richelsoph, Leasa C. Miller
  • Publication number: 20030185903
    Abstract: A composition includes calcium sulfate hemihydrate, stearic acid, an accelerant, and a mixing solution. The composition can be injected, e.g., through a needle, and is capable of setting, e.g., in vivo, in a relatively short period of time to a relatively high hardness.
    Type: Application
    Filed: March 28, 2003
    Publication date: October 2, 2003
    Inventors: Jantzen Cole, Timothy Smith
  • Patent number: 6627229
    Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.
    Type: Grant
    Filed: June 23, 2001
    Date of Patent: September 30, 2003
    Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
  • Patent number: 6565891
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: May 20, 2003
    Assignee: Tsar Health Private Ltd.
    Inventor: Ranjit Kumar Chandra
  • Patent number: 6562378
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: May 13, 2003
    Assignee: TSAR Health Private Ltd.
    Inventor: Renjit Kumar Chandra
  • Patent number: 6541038
    Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: April 1, 2003
    Assignee: SDS Biotech K.K.
    Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
  • Patent number: 6537589
    Abstract: An artificial bone promotive of osteoanagenesis comprising a calcium phosphate cement and a linear polyphosphate, wherein the calcium phosphate cement comprises &bgr;-tricalcium phosphate, monocalcium phosphate, calcium sulfate hemihydrate and other additives. The artificial bone is non-toxic to the body chemically stable, and has an excellent biodegradability. The artificial bone may be applied as substitutes for bone cements, allografts and autografts.
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: March 25, 2003
    Assignee: Kyung Won Medical Co., Ltd.
    Inventors: Soo Kyung Chae, Hong Yeoul Kim, Ho Yeon Lee, Chang Hun Lee, Kang Moon Seo
  • Patent number: 6524622
    Abstract: A method is designed to control the working time, setting time and the semi-solidification time of a gypsum composition in a bone restoration operation. The method involves a preparation of the gypsum composition by mixing an orthopedic gypsum and an aqueous solution in a weight ratio to form a semisolid substance which is to be injected into a patient under treatment. The aqueous solution contains serum, blood plasma, or whole blood, which is preferably taken from the patient under treatment.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: February 25, 2003
    Assignee: Central Medical Technologies Inc.
    Inventors: Shengfu Lin, Chih-I Lin, Horng Wei Pan, Shao-Wen Wu, Wen-Ching Say
  • Patent number: 6468550
    Abstract: A method of improving the photochromishm of a composition comprising at least one photochromic compound with an ionic conductor, and the composition thereof. The composition may, in particular, be in the form of a care and/or make-up product for the skin, a suncare or self-tanning product, or a haircare product.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: October 22, 2002
    Assignee: L'Oreal, S.A.
    Inventor: Christophe Remy
  • Patent number: 6416790
    Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: July 9, 2002
    Assignee: Aqua Med, Inc.
    Inventor: John D. Young
  • Patent number: 6322821
    Abstract: A composition for preventing and treating milk fever in freshening cows, and a method of administering the composition. The basic composition is a mixture of water, calcium chloride, propylene glycol, B vitamins and minerals. The calcium content is lower than conventional calcium treatments used for this purpose. The propylene glycol gives the cow an energy boost and sweetens the taste so the cow does not object to it as it does to conventional gels and liquids. The B vitamins stimulate the cow's appetite. The minerals replace minerals lost in the milk and also help the cow absorb calcium. The composition of the present invention is in a liquid form and is preferably administered using a 200-300 cc drench gun. The end of the dispensing tube of the drench gun is placed between the teeth and cheek of the cow near the receptors that stimulate the esophageal groove reflex.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: November 27, 2001
    Inventor: Jack W. Register
  • Patent number: 6287548
    Abstract: The present invention provides a composition of matter which has been demonstrated to be a very effective treatment for acne, seborrheic dermatitis and related skin diseases when applied to and contacted with affected skin areas, while avoiding the disadvantages and complications attendant to more established treatments. The composition comprises a synthetic mixture of salts which, when dissolved in a solvent such as water, is ionically composed primarily of a mixture of sodium and magnesium cations and chloride and sulfate anions, and which is preferably free of added zinc. More specifically, the salt mixture according to the present invention comprises the following range of composition in grams/kilogram of salt mixture in the ionic state, the balance being water of hydration: I.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: September 11, 2001
    Assignee: Bio.Life International AG
    Inventor: Hans F. Biener